MXCT EBITDA Margin
Maxcyte Inc · EBITDA Margin
MXCT EBITDA Margin
Latest reported-99.24%period ending
MXCT TTM EBITDA Margin (-16.52% → -99.24%)
TTM ebitda margin
High-resolution chart · PNG
MXCT ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -99.2432% | |
| -105.9467% | |
| -119.5664% | |
| -118.3038% | |
| -112.0854% | |
| -99.0259% | |
| -95.1124% | |
| -68.8076% | |
| -74.2876% | |
| -79.3306% | |
| -88.2904% | |
| -95.0306% | |
| -71.2179% | |
| -65.9437% | |
| -47.1331% | |
| -51.0618% | |
| -42.8475% | |
| -36.2851% | |
| -49.0168% | |
| -44.1709% | |
| -51.1351% | |
| -49.2811% | |
| -38.1619% | |
| -38.9102% | |
| -35.0206% | |
| -44.1061% | |
| -54.6074% | |
| -61.0861% | |
| -68.8205% | |
| -59.0745% | |
| -48.4844% | |
| -56.1655% | |
| -64.8716% | |
| -65.1383% | |
| -65.4187% | |
| -54.786% | |
| -43.3586% | |
| -32.6704% | |
| -21.335% | |
| -15.9769% | |
| -9.7515% | |
| -8.5518% | |
| -7.1881% | |
| -8.5783% | |
| -10.1154% | |
| -13.064% | |
| -16.522% |